Person living with dementia
depression, primary BPSD, Montgomery-Asberg Depression
DISEASE
The primary BPSD outcome of the study is the NPI-Q severity of the PwD at 90 days post-randomisation. Secondary outcomes include NPI-Q severity at 180 days post-randomisation, quality of life (measured by the Quality of Life-Alzheimer’s Disease [QoL-AD]) at 90 and 180 days post-randomisation, depression (measured by Montgomery-Asberg Depression Rating Scale [MADRS]) at 90 and 180 days post-randomisation and cognition (measured by Mini-Mental State Examination Score [MMSE]) at 90 days post-randomisation.